Related Experiment Video
Updated: Jul 6, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Emerging therapies for melanoma
Rajini Katipamula1, Svetomir N Markovic
1Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. katipamula.rajini@mayo.edu
Abstract:
Substantial progress has been made in understanding the pathogenesis of malignant melanoma at the cellular level, leading to the development of several new agents in the treatment of melanoma. The focus of this review is to summarize the emerging therapies and investigational agents in the treatment of melanoma over the last 5 years.
Insights
Recent advancements in understanding malignant melanoma pathogenesis have spurred new treatment agents. This review summarizes emerging therapies and investigational drugs for melanoma treatment over the past five years.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Malignant melanoma pathogenesis is increasingly understood at the cellular level.
- This cellular understanding has driven the development of novel therapeutic agents.
- Significant progress has been made in melanoma treatment strategies.
Purpose of the Study:
- To review emerging therapies for malignant melanoma.
- To summarize investigational agents in melanoma treatment.
- To cover advancements in the last five years.
Main Methods:
- Literature review of scientific publications.
- Analysis of clinical trial data.
- Synthesis of information on novel therapeutic agents.
Main Results:
- Identification of several promising new agents for melanoma treatment.
- Overview of the current landscape of investigational therapies.
- Highlighting of recent progress in cellular pathogenesis understanding.
Conclusions:
- Emerging therapies show significant potential in treating malignant melanoma.
- Continued research into investigational agents is crucial for advancing melanoma care.
- The last five years have seen notable progress in therapeutic options for melanoma.
Related Concept Videos
Tumor Immunotherapy
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

